Nav: Home

ARRS to host abdominal and pelvic MR imaging event

June 15, 2016

Leesburg, VA, June 15, 2016-- ARRS, working in conjunction with its members, will hold the 2016 ARRS Abdominal and Pelvic MR Imaging Symposium Sept. 30-Oct. 1, 2016, at the Renaissance Baltimore Harborplace Hotel in downtown Baltimore. Program hosts are Dr. Fergus Coakley, program director, professor and chair, department of diagnostic radiology, Oregon Health and Science University, Portland, OR; and Dr. Courtney Moreno, associate program director and assistant professor of radiology and director of ultrasound, department of radiology and imaging sciences, Emory University, Atlanta.

"The symposium is designed for all general and subspecialty radiologists whose work involves performing or interpreting MRI of the abdomen and pelvis for gastrointestinal, genitourinary, or other indications," Coakley said.

The program incorporates practical and cutting-edge reviews given by leading national experts in body MRI across a range of applications, including hepatic imaging, pancreaticobiliary disease, genitourinary disease, gynecology, gastrointestinal conditions, and other hot topics. Talks will be practical, emphasizing real-life clinical scenarios, and will provide tips and tricks to optimize study performance and interpretation.

Faculty scheduled to lecture are among the field's most distinguished leaders in radiology. Here's a look at some of the highlights:
  • Adnexal Masses: When to Use MRI. Presented by Dr. Liina Poder, associate professor of clinical radiology, department of radiology and biomedical imaging, University of California, San Francisco. Poder's lecture considers the importance of understanding and mastering of multimodality US/CT/MR imaging of the female pelvis. Poder will provide a case-based approach to adnexal pathology with a management algorithm. The emphasis will be on recognizing obviously benign and malignant characteristics of adnexal lesions as well and confirming the benign nature of complex adnexal processes. Advances in use of MRI and PET/MRI will be discussed in facilitating definitive diagnosis.
  • LI-RADS: MRI Algorithm and Criteria. Dr. Claude Sirlin, professor and vice chair (translational research) of radiology, and director, liver imaging group, University of California, San Diego, will discuss the Liver Imaging and Reporting System (LI-RADS). This is an American College of Radiology initiative to standardize and improve all aspects of liver cancer imaging with the hope of advancing knowledge, improving clinical care, facilitating research, informing clinical practice guidelines and health policy, and ultimately prolonging and improving the lives of the millions of people worldwide with or at risk for developing this fatal malignancy. Sirlin will review the current status and future directions of LI-RADS.
  • Learning Important Emerging Techniques Such as MR Guided Prostate Biopsy. According to Coakley, MRI-targeted biopsy of the prostate promises to radically change the current diagnostic approach to prostate cancer, which consists of essentially blind biopsies of standard locations within the prostate. No other cancer is diagnosed like this, and appropriate use of MRI guidance can reduce both overdiagnosis and underdiagnosis. Coakley will provide an overview of the current methods of MR guidance, and explain how a multidisciplinary team approach combining urology and radiology expertise can optimize prostate cancer diagnosis.
-end-
To learn more about the symposium, visit the ARRS website at http://www.arrs.org/ and click on the education tab. Media interested in attending the symposium should contact Kim Coghill, ARRS communications manager, at kcoghill@arrs.org.

Founded in 1900, ARRS is the first and oldest radiology society in the United States, and is an international forum for progress in radiology. The Society's mission is to improve health through a community committed to advancing knowledge and skills in radiology. ARRS achieves its mission through an annual scientific and educational meeting, publication of the American Journal of Roentgenology (AJR) and InPractice magazine, topical symposia and webinars, and print and online educational materials. ARRS is located in Leesburg, VA.

American Roentgen Ray Society

Related Prostate Cancer Articles:

ASCO and Cancer Care Ontario update guideline on radiation therapy for prostate cancer
The American Society of Clinical Oncology (ASCO) and Cancer Care Ontario today issued a joint clinical practice guideline update on brachytherapy (internal radiation) for patients with prostate cancer.
Patient prostate tissue used to create unique model of prostate cancer biology
For the first time, researchers have been able to grow, in a lab, both normal and primary cancerous prostate cells from a patient, and then implant a million of the cancer cells into a mouse to track how the tumor progresses.
Moffitt Cancer Center awarded $3.2 million grant to study bone metastasis in prostate cancer
Moffitt researchers David Basanta, Ph.D., and Conor Lynch, Ph.D., have been awarded a U01 grant to investigate prostate cancer metastasis.
New findings concerning hereditary prostate cancer
For the first time ever, researchers have differentiated the risks of developing indolent or aggressive prostate cancer in men with a family history of the disease.
Prostate cancer discovery may make it easier to kill cancer cells
A newly discovered connection between two common prostate cancer treatments may soon make prostate cancer cells easier to destroy.
New test for prostate cancer significantly improves prostate cancer screening
A study from Karolinska Institutet in Sweden shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
The dilemma of screening for prostate cancer
Primary care providers are put in a difficult position when screening their male patients for prostate cancer -- some guidelines suggest that testing the general population lacks evidence whereas others state that it is appropriate in certain patients.
Risk factors for prostate cancer
New research suggests that age, race and family history are the biggest risk factors for a man to develop prostate cancer, although high blood pressure, high cholesterol, vitamin D deficiency, inflammation of prostate, and vasectomy also add to the risk.
Prostate cancer is 5 different diseases
Cancer Research UK scientists have for the first time identified that there are five distinct types of prostate cancer and found a way to distinguish between them, according to a landmark study published today in EBioMedicine.
UH Seidman Cancer Center performs first-ever prostate cancer treatment
The radiation oncology team at UH Seidman Cancer Center in Cleveland performed the first-ever prostate cancer treatment April 3 using a newly-approved device -- SpaceOAR which enhances the efficacy of radiation treatment by protecting organs surrounding the prostate.

Related Prostate Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...